BREAKING
Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin 6 minutes ago Ultralife Corp (ULBI) Reports a net loss for Q4 FY25 15 minutes ago Protara Therapeutics, Inc. (TARA) Reports Narrower Loss for Q4 31 minutes ago Apyx Medical Corporation (APYX) Reports a Net Loss for Q4 FY25 42 minutes ago Esperion Therapeutics, Inc (ESPR) Misses Q4 EPS Estimates 54 minutes ago Inspired Entertainment, Inc (INSE) Misses Q4 EPS Estimates 1 hour ago DNTH Stock Jumps 21.5% Despite Wider-Than-Expected Q4 Loss as Pipeline Prospects Fuel Rally 2 hours ago SuRo Capital Corp (SSSS) Reports Wider Loss Q4 EPS Estimates by 10.0% 2 hours ago Tenax Therapeutics Inc (TENX) Reports Q4 Earnings 3 hours ago Bloom Energy (BE) Surges 12% Despite Adjusted Loss of $0.30 Per Share, Weak Q1 Outlook 4 hours ago Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin 6 minutes ago Ultralife Corp (ULBI) Reports a net loss for Q4 FY25 15 minutes ago Protara Therapeutics, Inc. (TARA) Reports Narrower Loss for Q4 31 minutes ago Apyx Medical Corporation (APYX) Reports a Net Loss for Q4 FY25 42 minutes ago Esperion Therapeutics, Inc (ESPR) Misses Q4 EPS Estimates 54 minutes ago Inspired Entertainment, Inc (INSE) Misses Q4 EPS Estimates 1 hour ago DNTH Stock Jumps 21.5% Despite Wider-Than-Expected Q4 Loss as Pipeline Prospects Fuel Rally 2 hours ago SuRo Capital Corp (SSSS) Reports Wider Loss Q4 EPS Estimates by 10.0% 2 hours ago Tenax Therapeutics Inc (TENX) Reports Q4 Earnings 3 hours ago Bloom Energy (BE) Surges 12% Despite Adjusted Loss of $0.30 Per Share, Weak Q1 Outlook 4 hours ago
ADVERTISEMENT
Market News

Flushing Financial Corp (FFIC): SWOT Analysis

Strengths Weaknesses Opportunities Threats

$FFIC January 28, 2026 1 min read
Market News
NYSE
$FFIC · Earnings

Strengths Weaknesses Opportunities Threats

Strengths

  • NIM Expansion: Sequential improvement in net interest margin to 2.68% indicates effective deposit pricing.
  • Core Profitability: 128.6% year-over-year increase in core EPS demonstrates operational recovery.
  • Capital Position: Tangible common equity ratio improved to 8.14%, up 32 basis points from the prior year.

Weaknesses

  • CRE Concentration: High exposure to New York real estate at 465% of total capital remains a regulatory focal point.
  • Missed Estimates: Q4 revenue and core EPS fell slightly below consensus analyst expectations.
  • GAAP Volatility: Sensitivity to fair value adjustments led to a wide gap between GAAP ($0.12) and Core ($0.32) EPS.

Opportunities

  • Transformational Merger: Combination with OceanFirst provides greater scale and a $225 million equity infusion.
  • Deposit Mix: 12% growth in noninterest-bearing deposits reduces the overall cost of funds.
  • Liquidity: Strong liquidity position with $3.9 billion in available funds as of year-end 2025.

Threats

  • Real Estate Macro: Continued pressure on office and multi-family valuations in the New York market.
  • Regulatory Hurdles: Pending merger completion is subject to standard regulatory approvals and closing conditions.
  • Trade Policy: Indirect impact of tariffs on the local commercial and industrial (C&I) borrower base.
ADVERTISEMENT